TrialAdvances in therapy2017

Estimating Long-Term Survival of Adults with Philadelphia Chromosome-Negative Relapsed/Refractory B-Precursor Acute Lymphoblastic Leukemia Treated with Blinatumomab Using Historical Data.

Arie Barlev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.